Up 700%, DexCom Stock Still Has Tons of Room To Run

Even with significant success over the past four years, DexCom (NASDAQ: DXCM) appears set to continue its growth in 2022 and beyond. In this segment of "The Earnings Show" on Motley Fool Live, recorded on Feb. 11, Fool contributors Taylor Carmichael and Brian Withers discuss the medical device company's encouraging outlook.

Continue reading

Source Fool.com